Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

LabRoots Announces Inaugural Online Virtual Event - Opioid Crisis, Scheduled on November 5th, 2020
  • USA - English

This educational focused agenda will share perspectives, valuable insights, and stellar expertise to tackle this complex issue and the evolving landscape of Opioid Management


News provided by

LabRoots

Oct 29, 2020, 10:00 ET

Share this article

Share toX

Share this article

Share toX

Opioid Crisis, November 5, 2020
Opioid Crisis, November 5, 2020

YORBA LINDA, Calif., Oct. 29, 2020 /PRNewswire-PRWeb/ -- LabRoots, the leading scientific social networking website, offering premier, interactive virtual events and webinars, today announced its new virtual event, Opioid Crisis to be held on November 5th, 2020. Free to attend, this high-level forum is designed to inform and raise awareness about critical substance use prevention and effective standards of care and showcase innovative strategies and practices to manage the opioid epidemic.

Opioid overdose deaths in the United States have increased dramatically over the past decade and continues to gain national attention. Key academia is actively engaged in this battle to enhance medical education and clinical care to physicians about pain management and substance use disorders (SUDs) to respond to this crisis. This program, bringing together thousands of leaders from industry and academic institutions, research scholars, clinicians, healthcare and behavioral professionals, includes a variety of informative topics such as medications for opioid use disorder, stigma surrounding opioid use disorder, informatics and opioid stewardship, and health system delivery of opioid use disorder treatments.

The full line up of notable speakers will concentrate on many facets of opioid response while exploring buprenorphine induction strategies and comparing traditional and home induction methods and identifying appropriate patient populations for each method, stigma toward medication assisted treatment (MAT) and articulating the components of stigma, understanding the three types of stigma and how stigma can impact social support, the disease state model of substance use disorder and the evidence surrounding common misconceptions regarding substance use disorder, the importance of educating patients and their physicians on opioid use: lessons learned from medical cases, and compliance to pain management test results based in prescriptions and the important pain management medications in use today and the routes of metabolism, and how to interpret pharmacogenomics variances in the genes that encode cytochrome P450 with relevance to pain medication, to round out the day.

An impressive keynote delivery kicks off the event presented by Professor Bertha Madras (the Honorable) titled, 'The Opioid Crisis: Made in America…Fade in America.' "Opioid overdose deaths in the United States are approximately nine times higher than in the European Union. The opioid crisis was made in America, but when will it fade in America? Initially catalyzed by misuse of prescription drugs, from 2010 onwards the cause of deaths began to shift with the advent of inexpensive heroin and fentanyl marketed to opioid-seeking populations. The COVID-19 pandemic is fueling this unprecedented crisis, with 2020 predicted to witness at minimum, an 8% rise in drug-related deaths," said Bertha Madras, Professor of Psychobiology at Harvard Medical School and Director of the Laboratory of Addiction Biology at McLean Hospital. "The LabRoots' presentation will highlight the complex origins of the crisis, outline the need to reverse engineer initial mistakes in the healthcare system, and describe broadly-based solutions, along with challenges to implementation: rising normalization of drug use, persistent barriers to effective treatment, and COVID-related disruptions of normalcy."

In addition to the featured expert discussions, a panel presentation: 'The NIH HEAL Initiative: A Bold Interagency Response to the Opioid Crisis,' highlights the program schedule describing the Helping to End Addiction Long-TermSM Initiative, or NIH HEAL InitiativeSM, a trans-NIH research effort focused on improving prevention and treatment of opioid misuse and addiction and enhancing pain management. Attendees will learn firsthand how the NIH HEAL Initiative is addressing unmet research needs to curb the opioid crisis and understand the extent of the U.S. opioid epidemic, and how widespread use of prescription opioids and the lack of effective pain treatment fueled the crisis.

"Dealing with opioid addiction is one of the most significant problems the U.S. and the health system faces today, and we are pleased to add this topic of crucial interest to our event schedule this year," commented Greg Cruikshank, Chief Executive Officer at LabRoots. "LabRoots' one-stop platform continues to deliver educational sessions to the scientific community while bringing vital issues to the forefront - specifically discussing in depth the history of opioids, addressing the impact of opioid abuse, and defining clinical approaches to treating substance use disorder to aid in managing and reducing the opioid epidemic and improve the health of our communities."

Produced on LabRoots' robust platform with the capability to connect across all desktop and mobile devices, the interactive environment encompasses a lobby, auditorium, poster hall, exhibit hall, and networking lounge allowing a complete educational experience for all participants. As an approved provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E. Program, LabRoots offers the opportunity to earn 1 Continuing Education Credit per presentation for a maximum of 14 credits.

To register and for more information, click here. Use #LRopioids to follow the conversation!

About LabRoots
LabRoots is the leading scientific social networking website, and primary source for scientific trending news and premier educational virtual events and webinars and more. Contributing to the advancement of science through content sharing capabilities, LabRoots is a powerful advocate in amplifying global networks and communities. Founded in 2008, LabRoots emphasizes digital innovation in scientific collaboration and learning. Offering more than articles and webcasts that go beyond the mundane and explore the latest discoveries in the world of science, LabRoots users can stay atop their field by gaining continuing education credits from a wide range of topics through their participation in the webinars and virtual events.

SOURCE LabRoots

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.